Investing.com -- TD Cowen downgraded Celsius Holdings (NASDAQ:CELH) to Hold and slashed its price target for the stock to $29 from $40 in a note Wednesday, citing slowing sales growth ...

In a report released yesterday, Jeff Osborne from TD Cowen maintained a Hold rating on Visteon (VC – Research Report), with a price target of $117.00. The company’s shares opened today at $86.23.

TD Cowen analyst Jeff Osborne maintained a Buy rating on Cerence (CRNC – Research Report) yesterday and set a price target of $15.00. The company’s shares opened today at $14.52. Osborne ...

Investing.com -- LVMH is well-positioned for long-term success, despite some near-term challenges, according to analysts at TD Cowen. The bank maintains a positive outlook on the luxury giant ...

In a report released yesterday, Jeff Osborne from TD Cowen maintained a Buy rating on Aspen Aerogels (ASPN – Research Report), with a price target of $25.00. The company’s shares opened today ...

On Tuesday, TD Cowen analysts adjusted their outlook for shares of Charles River Laboratories International Inc. (NYSE: CRL), reducing the price target from $227.00 to $182.00 while maintaining a ...

TD Cowen analyst Thomas Fitzgerald CFA maintained a Hold rating on JetBlue Airways (JBLU – Research Report) on January 17 and set a price target of $6.00. The company’s shares closed today at ...

TD Cowen analyst Doug Creutz maintained a Buy rating on Electronic Arts (EA – Research Report) today and set a price target of $183.00. The company’s shares closed yesterday at $142.35.

On Tuesday, Forte Biosciences Inc. (NASDAQ:FBRX), a biotech company with a market capitalization of approximately $100 million, received a new Buy rating from TD Cowen, as the firm began its ...

In a report released today, Yaron Werber from TD Cowen maintained a Hold rating on Genmab (GMAB – Research Report). The company’s shares opened today at $21.35. Werber covers the Healthcare ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price target of $371.00. The company’s shares opened today at ...